Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

CAPS Rating: 4 out of 5

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

Recs

1
Player Avatar mikephilipsoh (< 20) Submitted: 6/8/2011 4:45:16 PM : Outperform Start Price: $19.48 MNTA Score: -31.85

This company has a number of drug candidates in its pipeline.

Featured Broker Partners


Advertisement